Barzin Y. Nabet

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 864 citations · Full text

Immunogenetics, Systems Biology, Distinct Therapeutic Vulnerabilities +11

Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways

Mirjam C. Boelens, Tony J. Wu, Barzin Y. Nabet et al. · Cell · 2014 · 782 citations · Full text

Breast Oncology, Exosomes, Medicine +12

Integrating genomic features for non-invasive early lung cancer detection

Jacob J. Chabon, Emily G. Hamilton, David M. Kurtz et al. · Nature · 2020 · 655 citations · Full text

Engineering, Cancer Detection, Genomic Features +8

Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer

Barzin Y. Nabet, Yu Qiu, Jacob E. Shabason et al. · Cell · 2017 · 440 citations · Full text

Chromatin, Exosomes, Natural Sciences +10

Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

Namrata S. Patil, Barzin Y. Nabet, Sören Müller et al. · Cancer Cell · 2022 · 371 citations

Intratumoral Plasma Cells, Cancer Immunosurveillance, Pd-l1 Blockade +8